ImageneBio, Inc.
IMANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $68.20M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.90$9.10
- Volume (live)
- -
- Avg. volume (3M)
- 14.85K
ImageneBio (IMA) Stock Price & Financial Analysis
ImageneBio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.98 - $4.30 |
|---|---|
| 52-Week High | $9.10 |
| 52-Week Low | $3.90 |
| Open | $3.98 |
| Volume (last close) | 7.87K |
| Average Volume (3M) | 14.85K |
| 50-Day MA | $4.93 |
|---|---|
| 200-Day MA | $5.74 |
| 1-Year Change | −45.26% |
| Market Cap | 68.20M |
|---|---|
| Shares Outstanding | 16.16M |
| Price to Book (P/B) | 0.48 |
| EV/EBITDA | 0.47 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
ImageneBio at a Glance
As of the Oct 23, 2026 close, ImageneBio (IMA) has a market capitalization of $68.20M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $94.68M in cash and securities against $1.91M of debt, a net cash position of $92.77M.
ImageneBio does not currently pay a dividend.
The share price is down 45.3% over the past year. At $4.22 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $3.90 to $9.10, below its 200-day moving average of $5.74.
Frequently Asked Questions About ImageneBio
What is the current stock price for IMA?
As of the Oct 23, 2026 close, IMA stock trades at $4.22. The 52-week range is $3.90–$9.10, with a day range of $3.98–$4.30.
What is the P/E ratio for IMA?
The P/E ratio (Price-to-Earnings) for IMA is shown in the Key Statistics section. This valuation metric helps compare ImageneBio, Inc. to industry peers.
Does IMA pay dividends?
ImageneBio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMA?
Analyst ratings and recommendations for IMA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IMA?
As of the Oct 23, 2026 close, ImageneBio's market capitalization is $68.2M, classifying it as a micro-cap company. ImageneBio operates in the Healthcare sector within the Biotechnology industry.